Yeah I've been watching that as well, and that's despite the fact that EYE has been growing revenues significantly faster and arguably has a better device. I guess they benefit from their US listing and higher market cap, which attracts many more institutional investors (who are clearly interested in the sector). This does go to show what we can expect to see when this stock finally moves into the spotlight, and gets a market cap large enough for institutional investors to accumulate on market.
Nova Eye Medical (EYE) Discussion, page-2940
-
- There are more pages in this discussion • 248 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.8¢ |
Change
-0.008(4.84%) |
Mkt cap ! $33.78M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 15.5¢ | 14.5¢ | $61.97K | 415.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 205625 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 3000 | 1 |
View Market Depth
| Last trade - 15.44pm 05/11/2024 (20 minute delay) ? |
| EYE (ASX) Chart |